Infection is the only proven mechanism of disease leading to premature delivery. Microbiological and histopathological studies suggest that infection-related inflammation may account for 25% to 40% of cases of preterm deliveries.
201,202,203 The evidence supporting the role of infection in the onset of labor includes the following: (1) systemic maternal infection is associated with the onset of labor and these patients have a higher frequency of PTB; (2) intrauterine infection is associated with spontaneous preterm parturition; and (3) in animal models, intrauterine injection of bacteria or bacterial products leads to preterm delivery.
201,202,203 Infectious processes leading to PTB can be clinically evident (ie, pyelonephritis or chorioamnionitis); subclinical, limited to the uterus,
and present as PTL or preterm PROM, resulting from bacteria that crossed through the placenta from the maternal blood and are detected in the amniotic fluid; and/or detected only after delivery in the placenta (ie, acute histologic chorioamnionitis) (
Figure 49.8).
Intra-amniotic Infection
The presence of bacteria or other microorganisms in the amniotic fluid, which should be sterile,
213 is associated with adverse pregnancy outcomes.
164,171,172,173,174,175,176,214,215,216,217,218,219,220,221,222,223,224,225 Intrauterine infection is a frequent and important mechanism of disease leading to premature contraction, PTL, and PTB.
166,201,203,226,227,228,229,230,231,232,233 Intra-amniotic infection is a chronic process,
234 and identification of microorganisms during mid-trimester amniocentesis in asymptomatic patients has been associated with subsequent late miscarriage,
235 preterm delivery,
236 and even fetal demise.
171,172,173,174,175,176,237
Pathogenic microorganisms can invade the amniotic fluid through several routes. The most common is ascending infection from the vagina to the cervical canal through the membranes into the amniotic cavity and subsequently infecting the
membranes and the fetus.
201,238 Other routes are maternal transmission of bacteria by hematogenous
239,240,241 spread through the placenta or through the membranes, and finally iatrogenic introduction of bacteria into the amniotic cavity during amniocentesis of other medical intervention
242,243 (
Figure 49.9).
Goncalves et al
226 reported that the overall prevalence of intra-amniotic infection in patients with PTL was 12.8% and about 50% were polymicrobial. The rate of microbial invasion of amniotic cavity (MIAC) in patients with PTL and intact membrane is gestational age dependent, ranging from as high as 45% at 23 to 26 weeks to 11.5% by 31 to 34 weeks of gestation.
244 Thus, the earlier the gestational age in which PTL develops, the more likely that MIAC is present.
244
The diagnosis of MIAC using standardized cultivation techniques is limited by the number of bacteria detected and by the interval from sample collection to bacterial growth and identification in cultures. The introduction of 16s ribosomal DNA-polymerase chain reaction (PCR) techniques has improved the detection rate of MIAC.
238,245,246,247,248,249 Indeed, in a study of amniotic fluid samples from 166 patients with PTL and intact membranes, the overall rate of positive cultures was 15.06% (25/166), of them 24% (6/25) had only positive amniotic fluid cultures, 36% (9/25) had only positive amniotic fluid 16s rDNA PCR, and in 40% (10/25) both tests were positive.
246 A study by Combs et al reported that patients with PTL and intact membranes had a rate of MIAC of 10.1% (31/305), of them 65% (20/31) had both tests positive, 19% (6/31) had only 16s rDNA-PCR positive, and 16% (5/31) only cultures positive.
245 These observations have clinical implications since in women presenting with PTL, a positive 16s rDNA-PCR test for microbial invasion had a positive predictive value of 100% for preterm delivery <37, <32, or <25 weeks of gestation and 68% for delivery within 1 day of amniocentesis.
246 Recently, a novel molecular microbiologic technique that includes 16s PCR and electrospray ionization time-of-flight mass spectrometry (PCR/ESI-MS).
250 This method can yield results within 8 hours of amniotic fluid collection and therefore in time for clinical decision. The authors reported that the introduction of this method increased the detection rate of microbial of amniotic fluid by 100% and increased the positive predictive value for spontaneous preterm delivery before 37 or 32 weeks, delivery within 7 or 2 days of amniocentesis.
250 Collectively these studies suggest that there is a role for the introduction of novel molecular microbiologic techniques in the clinical workup of amniotic fluid for the detection of intra-amniotic infection in patients with PTL and intact membranes.
The most common microbial organisms isolated (either by culture or by 16s PCR) from the amniotic fluid of patients with PTL and intact membranes were genital mycoplasmas; followed by
Fusobacterium species,
201 Streptococcus agalactiae, Peptostreptococcus spp.
, Fusobacterium spp.
, Staphylococcus aureus, Gardnerella vaginalis, Streptococcus viridans, and
Bacteroides spp.
202,251,252,253,254,255,256,257,258,259 (
Figure 49.10).
Bacteria in amniotic fluid can be either planktonic (free floating) or in the form of biofilm.
260,261 The latter is more challenging since bacteria use biofilms to avoid the host inflammatory response and are more difficult to isolate in standard cultivation
techniques, and such infections are often underdiagnosed. Amniotic fluid sludge, which is a particulate matter identified by ultrasound near the internal os of the uterine cervix, is in fact in part of the cases a bacterial biofilm
260,261 (
Figure 49.11). The identification of sludge in asymptomatic patients and in those at risk for PTB, especially when accompanied by a short sonographic cervix, is associated with an increased risk for spontaneous PTL with intact membranes, PPROM of membranes, microbial invasion of amniotic fluid, PTB, and histologic chorioamnionitis.
262,263
Inflammation has a seminal role in the process of term and preterm parturition. However, while in labor at term, inflammation is a physiologic phenomenon. In the context of PTL, intra-amniotic inflammation that initiates preterm parturition is derived from pathological processes such as intra-amniotic infection or sterile inflammation.
5,202,264,265,266,267,268
Microbial invasion of amniotic fluid can be either isolated (colonization) or as microbial associated intra-amniotic inflammation. This distinction has clinical significance, in a nested case control study of asymptomatic women who underwent mid-trimester genetic amniocentesis at 16 to 18 weeks of gestation
269: (1) Women who delivered preterm had higher amniotic fluid concentrations of interleukin (IL)-6 and tumor necrosis factor (TNF) than those who delivered at term; (2) mid-trimester amniotic fluid IL-6 concentration ≥ 99.3 pg/mL had a sensitivity of 89.6%, specificity of 80.2%, and RR of 11.4 (95% CI 4.8-27.0) for preterm delivery <37 weeks of gestation; (3) mid-trimester amniotic fluid IL-6 concentration ≥ 99.3 pg/mL had a sensitivity of 91.9%, specificity of 73.8%, and RR of 15.0 (95% CI 4.8-45.5) for a positive amniotic fluid culture; (4) mid-trimester amniotic fluid TNF concentrations ≥ 6.6 pg/mL had a sensitivity of 81.3%, specificity of 79.2%, and RR of 6.2 (95% CI 3.3-11.9) for preterm delivery <37 weeks of gestation; and (5) mid-trimester amniotic fluid TNF concentrations ≥ 6.3 pg/mL had a sensitivity of 78.4%, specificity of 70.1%, and RR of 4.9 (95% CI 2.4-10.0) for positive amniotic fluid culture. Of interest, among those who delivered preterm, 47.9% had a positive mid-trimester amniotic fluid culture and elevated IL-6 and 45.8% had a positive mid-trimester amniotic fluid culture and elevated TNF, while among those who delivered preterm, the corresponding rates were 11.5% and 7.3%, respectively. Of interest, the rate of PTBs with those who had a positive amniotic fluid culture with elevated IL or TNF were 4.2% and 6.3%, respectively. Nevertheless, negative amniotic fluid cultures with elevated IL-6 or TNF were present in 41.7% and 35.4% of preterm deliveries.
269 This report and others
164,201,202,203,215,225,245,270,271,272,273 suggest that the inflammatory process elicited by the presence of microbacteria in the amniotic cavity is the driving force that leads to preterm parturition in cases of MIAC.
In cases of microbial associated intra-amniotic inflammation, the inflammatory reaction in the amniotic fluid is triggered by the activation of pattern recognition receptors including toll-like receptors or RAGE in response to the presence of danger-associated molecular patterns (DAMPs) or pathogen-associated molecular patterns (ie, lipopolysaccharides).
274 The activation of pattern recognition receptors (PPRs) by microbes or their products illicits an inflammatory response, which in turn leads to the production of cytokines (IL-6 and TNFα) and matrix degrading enzymes (matrix metalloproteinase [MMP]-8), leading to the production of prostaglandins and activation of the common pathway of parturition
6 (
Figure 49.8).
Sterile Intra-amniotic Inflammation
Inflammatory processes in the amniotic fluid in which microorganisms cannot be detected are defined as sterile intra-amniotic inflammation. This process is activated by the presence of DAMPs in the amniotic fluid. These are endogenous intracellular molecules that are exposed during unprogrammed cellular death and can serve as a preliminary sign of tissue injury. DAMPs are also referred to as alarmins, and prominent members of this family are high-mobility group box 1 (HMGB1), uric acid, IL-1α, S100 calcium binding protein B, uric acid, and cell-free DNA.
6,222,224,264,265,267,275,276,277,278,279,280 The generation of DAMPs activates the PPR that illicits an inflammatory response, which in turn leads to the production of cytokines (IL-6 and TNFα) and matrix degrading enzymes (MMP-8), leading to the production of prostaglandins and activation of the common pathway of parturition (
Figure 49.12).
Yoon et al
281 and others
245 reported that for any given gestational age, the rate of intra-amniotic inflammation is higher than that of MIAC (
Figure 49.13). The clinical characteristics of patients with PTL who had sterile intra-amniotic inflammation are similar in terms of gestational age at delivery, amniocentesis to delivery interval, and adverse neonatal outcomes, to those reported in women with PTL and microbial associated intra-amniotic inflammation.
221,245,281,282 Indeed, among patients with PTL, the amniotic fluid concentration of HMGB1 proteins is increased in both patients with sterile or microbial mediated intra-amniotic inflammation.
283 Moreover, the amniocentesis to delivery interval of patients with PTL and sterile amniotic fluid inflammation who had amniotic fluid HMGB1 concentration ≥8.55 pg/mL was similar to that of those with microbial associated intra-amniotic inflammation, and shorter than those with sterile intra-amniotic inflammation but HMGB1 concentration <8.55 pg/mL (
P = .02).
282 In a mice model, intra-amniotic administration of HMGB-1 leads to PTB.
283 In vitro evidence suggests a role for HMGB1 in activation of the chorioamniotic
membranes, leading to increased production of IL-6 and IL-8, and its extranuclear fraction is detected in the uterine cervix during term and PTL, suggesting a role in cervical ripening.
280 Moreover, intra-amniotic infection is associated with higher amniotic fluid concentrations of HMGB-1. Other alarmins, such as IL-1α and IL-1β, are implicated in spontaneous PTB as well.
In addition to IL-1 and TNFα, many other cytokines and chemokines (ie, IL-6, IL-8, IL-16, IL-18, colony-stimulating factor, macrophage migration inhibitory factor, monocyte chemotactic protein-1) are involved in the inflammatory process of microbial associated or sterile intra-amniotic inflammation.
274 These observations suggest that the process of intra-amniotic inflammation involves a network of cytokines and chemokines. Indeed, Romero et al demonstrated that in patients with PTL and intact membranes, microbial associated or sterile intra-amniotic inflammation are characterized by unique network of perturbed inflammatory-related protein concentration and correlations
284 (
Figure 49.14).
Maternal Antifetal Rejection
A novel inflammatory process leading to PTB is maternal antifetal rejection, a graft-versus-host response of the fetus and the mother. This process is associated with chronic placental inflammation, characterized by villitis of unknown etiology, chronic chorioamnionitis, and chronic deciduitis and is similar to the type of graft rejection observed in patients with failed heart, lung, and kidney transplant.
285 A high amniotic fluid concentration of C-X-C motif ligand (CXCL)-10 observed in patients with spontaneous preterm labor was associated with the presence of lesion consistent with chronic placental inflammation (villitis of unknown etiology, chronic chorioamnionitis, and chronic deciduitis).
285 This type of placental lesion is characterized by infiltration of lymphocytes, plasma cells, and histiocytes. The maternal antifetal rejection is characterized by (1) infiltration of maternal CD8+ T cells into fetal tissues; (2) the presence of antifetal human leukocyte antigen antibodies in maternal circulation; and (3) depositions of C4d in umbilical vein and syncytiotrophoblast
194 (
Figure 49.15). Chronic placental inflammatory lesions are the most common placental findings in late PTB but can be observed in the mid-trimester of patients who eventually have late-preterm delivery.
194 Maternal antifetal rejection is associated with fetal morbidity and mortality. Among preterm neonates born between 24 and 34 weeks of gestation, those who had periventricular leukomalacia (PVL) had a higher rate of placental chronic inflammatory lesions than those without it,
286 suggesting that processes associated with maternal antifetal rejection leading to PTL and PTB may be associated with long-term sequelae in the preterm infant.
Fetal Inflammatory Response Syndrome
Fetal inflammatory response syndrome (FIRS) can be considered the fetal equivalent of systemic inflammatory response syndrome, described in adults with sepsis.
287,288 FIRS is characterized by systemic activation of the fetal immune system involving all major fetal systems (ie, hematopoietic, heart, brain, lungs, kidneys, adrenals, and skin).
287,288,289 Additionally, preterm neonates affected in utero by FIRS have a shorter interval from cordocentesis to delivery and a higher rate of short- and long-term complication of prematurity including RDS, neonatal sepsis, pneumonia, bronchopulmonary dysplasia (BPD), intraventricular hemorrhage (IVH), PVL, NEC, and cerebral palsy than those without this syndrome.
287,290,291,292 The rate of FIRS in pregnancies complicated by preterm parturition is about 39% and increases to 49.3% in fetuses delivered within 1 week from cordocentesis.
287,293
Currently, there are two types of FIRS: type I and type II. Type I is considered the highest degree of intra-amniotic infection/inflammation. It describes fetuses who mounted a systemic inflammatory immune response to microorganisms that invaded the amniotic cavity. Type I FIRS is characterized by high cord blood concentrations of proinflammatory
cytokines, especially IL-6 and TNF-α. A concentration of 11 pg/mL of IL-6 detected in fetal cord blood is the cutoff for prenatal diagnosis of FIRS type I
281 as it was associated with adverse neonatal outcome and complications of prematurity. The characteristic placental lesions of FIRS type I syndrome include histologic chorioamnionitis, evidence of umbilical cord inflammation (funisitis), and chorionic vasculitis. The presence of funisitis allows a postnatal diagnosis of neonates with FIRS type I and is associated with an increased risk for the subsequent development of cerebral palsy (OR 5.5; 95% CI 1.2-24.5)
287,294,295 (
Figure 49.16).
Type II FIRS results from maternal antifetal rejection and manifests as a unique cord blood transcriptome in the affected fetuses. The clinical manifestations of FIRS type II await further research.
296 The summary of the characteristics of the two types of FIRS is depicted in
Figure 49.16.
Allergic Phenomena
Preliminary evidence suggest an allergic-like immune response (type I hypersensitivity) can be associated with PTL and delivery.
5,297 Indeed, case reports of women who had severe latex allergy
298 and developed uterine contraction as well as that of women who developed PTL and acute hypersensitivity reaction after ingestion of lobster meat that resolved with treatment by steroids antihistaminic medications
297 support this assumption. Type I hypersensitivity is defined as immunoglobulin (Ig)E-mediated hypersensitivity, in which the exposure of these antibodies to the allergens leads to mast cell activation, degranulation, and initiation of an inflammatory response and the section of histamine and prostaglandins and other products of mast cell degranulation can induce myometrial contractility.
299,300,301 The mast cell-mediated inflammatory response is characterized by the secretion
of IL-8, IL-3, and granulocyte-macrophage colony-stimulating factor (GM-CSF), which attract and activate eosinophils that enhance the inflammatory response by secreting leukotrienes, platelet activating factors, IL-4, and IL-10 as well as activation of proteases leading to tissue damage.
297 Indeed, among women who presented with PTL and had diagnostic amniocentesis without evidence of MIAC, those who had >20% eosinophils in their amniotic fluid blood cell count had a lower gestational age at delivery and a higher rate of PTB <35 and <37 weeks of gestation than those who had ≤20% eosinophils in their amniotic fluid blood cell count. This suggests that a subset of patients with PTL and a high number of eosinophils in their amniotic fluid has type I hypersensitivity-mediated PTB.